{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:04:31Z","timestamp":1785391471166,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities","award":["14ykpy08"],"award-info":[{"award-number":["14ykpy08"]}]},{"name":"Pearl River S&T Nova Program of Guangzhou","award":["2013J2200054"],"award-info":[{"award-number":["2013J2200054"]}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["21331007"],"award-info":[{"award-number":["21331007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","award":["21571194"],"award-info":[{"award-number":["21571194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NSF of Guangdong Province","award":["S2012030006240"],"award-info":[{"award-number":["S2012030006240"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejps.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T07:22:37Z","timestamp":1445584957000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation"],"prefix":"10.1016","volume":"85","author":[{"given":"Rui-Zhen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Bu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2015.10.006_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/mp060126o","article-title":"Cocrystal or salt: does it really matter?","volume":"4","author":"Aaker\u00f6y","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2015.10.006_bb0110","unstructured":"Ahn, J.H., Kim, U.S., Choi, A.R., 2011. Preparation of adefovir dipivoxil hemihydrate. KR Patent 2011024354A."},{"key":"10.1016\/j.ejps.2015.10.006_bb0140","series-title":"CrysAlisPro, Version 1.171.36.20","author":"Anon.","year":"2012"},{"key":"10.1016\/j.ejps.2015.10.006_bb0085","unstructured":"Arimilli, M.N., Kelly, D.E., Lee, T.T. K., Manes, L.V., Munger, J.D., Prisbe, E.J., Schultze, L.M., 2002. Nucleotide analog compositions. U.S. Patent 6451340 (B1)."},{"key":"10.1016\/j.ejps.2015.10.006_bb0100","doi-asserted-by":"crossref","first-page":"o1014","DOI":"10.1107\/S1600536807000736","volume":"E63","author":"Chang","year":"2007","journal-title":"Acta Crystallogr. E"},{"key":"10.1016\/j.ejps.2015.10.006_bb0030","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1039\/c2ce25724f","article-title":"Crystal engineering approach to improve the solubility of mebendazole","volume":"14","author":"Chen","year":"2012","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejps.2015.10.006_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/cg901010v","article-title":"Effects of crystal form on solubility and pharmacokinetics: a crystal engineering case study of lamotrigine","volume":"10","author":"Cheney","year":"2010","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2015.10.006_bb0025","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1021\/ja048114o","article-title":"Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids","volume":"126","author":"Childs","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2015.10.006_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1021\/mp0601345","article-title":"The salt-cocrystal continuum: the influence of crystal structure on ionization state","volume":"4","author":"Childs","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2015.10.006_bb0105","unstructured":"Galimi, S., Vecchio, E., Pizzocaro, R., 2009. Adefovir dipivoxil crystalline monohydrate form. WO Patent 015892A1."},{"key":"10.1016\/j.ejps.2015.10.006_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.2042-7158.2010.01246.x","article-title":"Enhanced dissolution and stability of adeforvir dipivoxil by cocrystal formation","volume":"63","author":"Gao","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2015.10.006_bb0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijpharm.2012.09.027","article-title":"Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil\u2013saccharin and adefovir dipivoxil\u2013nicotinamide cocrystals","volume":"438","author":"Gao","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2015.10.006_bb0045","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1021\/cg400518w","article-title":"Approach of cocrystallization to improve the solubility and photostability of tranilast","volume":"13","author":"Geng","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2015.10.006_bb0125","unstructured":"Gong, L., Wang, C., Li, G., 2011. Liquid capsule having high stability, comprises adefovir dipivoxil and vegetable oil including soybean oil. Chin. Patent 102824329-A."},{"key":"10.1016\/j.ejps.2015.10.006_bb0005","first-page":"393","article-title":"Reducing the risk of drug attrition associated with physicochemical properties","volume":"45","author":"Leeson","year":"2010","journal-title":"Annu. Rep. Med. Chem."},{"key":"10.1016\/j.ejps.2015.10.006_bb0080","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2015.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s11095-006-9032-3","article-title":"Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API","volume":"23","author":"McNamara","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.10.006_bb0015","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.ejps.2008.02.039","article-title":"Co-crystals: an emerging approach to improving properties of pharmaceutical solids","volume":"34","author":"Mirza","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.10.006_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/cg501542h","article-title":"Expanding the crystal form landscape of the antiviral drug adefovir dipivoxil","volume":"15","author":"Prohens","year":"2015","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2015.10.006_bb0010","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1021\/mp400516b","article-title":"Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt","volume":"10","author":"Sanphui","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2015.10.006_bb0145","series-title":"SHELXTL-97, Program for Crystal Structure Solution and Refinement","author":"Sheldrick","year":"1997"},{"key":"10.1016\/j.ejps.2015.10.006_bb0050","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1021\/cg500560w","article-title":"Solubility enhancement of ezetimibe by a cocrystal engineering technique","volume":"14","author":"Sugandha","year":"2014","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2015.10.006_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2015.06.004","article-title":"Pharmaceutical salts of ciprofloxacin with dicarboxylic acids","volume":"77","author":"Surov","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2015.10.006_bb0070","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/cg300327x","article-title":"Phenazopyridine cocrystal and salts that exhibit enhanced solubility and stability","volume":"6","author":"Tao","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejps.2015.10.006_bb0090","unstructured":"Wang, G., He, K., Zhao, H., Hou, J., Rao, P., 2006. Adefovir dipivoxil anhydrous crystal, preparation method and medicine composition thereof. CN Patent 101054393A."},{"key":"10.1016\/j.ejps.2015.10.006_bb0095","unstructured":"Wang, G., Lu, X., Liu, Q., Tang, Y., Yang, L., 2006. New crystal form of adefovir dipivoxil and its composition. U.S. Patent 0025384A1."},{"key":"10.1016\/j.ejps.2015.10.006_bb0040","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1039\/c3ce41017j","article-title":"Simultaneously enhancing the solubility and permeability of acyclovir by crystal engineering approach","volume":"15","author":"Yan","year":"2013","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ejps.2015.10.006_bb0120","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1023\/A:1026457729708","article-title":"Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil","volume":"17","author":"Yuan","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2015.10.006_bb0130","unstructured":"Yuan, J., Zhang, K., Ye, X., Zou, L., Ge, Y., 2005. Beta-cyclodextrin inclusion compound of adefovir dipivoxil and preparation thereof. Chin. Patent 1879635-A."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871530035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871530035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:45:26Z","timestamp":1760528726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871530035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":29,"alternative-id":["S092809871530035X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2015.10.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}